Compare Sana Biotechnology Inc (SANA) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Vanguard Emerging Markets Stock Index Fund ETF trades at $58.85. The key difference: Vanguard Emerging Markets Stock Index Fund ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | VWO | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | — |
52-Week High | $5.92 | $61.24 |
52-Week Low | $2.68 | $49.54 |
Enterprise Value | $848.03M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
